{"id":27206,"date":"2024-02-21T11:50:03","date_gmt":"2024-02-21T16:50:03","guid":{"rendered":"https:\/\/myeloma.ca\/?p=27206"},"modified":"2024-02-21T11:51:55","modified_gmt":"2024-02-21T16:51:55","slug":"le-belantamab-mafodotin-la-pomalidomide-et-la-dexamethasone-pour-traiter-les-patients-atteints-dun-myelome-multiple-refractaire-un-essai-de-phase-1-2-en-anglais-seulement","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2024\/02\/21\/le-belantamab-mafodotin-la-pomalidomide-et-la-dexamethasone-pour-traiter-les-patients-atteints-dun-myelome-multiple-refractaire-un-essai-de-phase-1-2-en-anglais-seulement\/","title":{"rendered":"Le b\u00e9lantamab mafodotin, la pomalidomide et la dexam\u00e9thasone pour traiter les patients atteints d\u2019un my\u00e9lome multiple r\u00e9fractaire\u202f: un essai de phase 1\/2 (en anglais seulement)"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">En raison de l\u2019\u00e9volution des normes de traitement d\u2019un my\u00e9lome multiple nouvellement diagnostiqu\u00e9, de nombreux patients seront expos\u00e9s aux trois classes de m\u00e9dicaments apr\u00e8s les premi\u00e8res rechutes et pr\u00e9senteront un faible taux de survie. De nouveaux traitements et de nouvelles combinaisons sont donc n\u00e9cessaires pour am\u00e9liorer les r\u00e9sultats des patients. Les m\u00e9dicaments biologiques ciblant l\u2019antig\u00e8ne de maturation des lymphocytes B (BCMA) sont apparus comme un nouveau domaine th\u00e9rapeutique important dans le traitement d\u2019un my\u00e9lome multiple r\u00e9cidivant. L\u2019essai ALGONQUIN en deux volets a \u00e9valu\u00e9 diff\u00e9rentes doses et diff\u00e9rents sch\u00e9mas du conjugu\u00e9 anticorps-m\u00e9dicament anti-BCMA b\u00e9lantamab mafodotin en association avec la pomalidomide et la dexam\u00e9thasone pour traiter les patients r\u00e9fractaires au l\u00e9nalidomide et expos\u00e9s aux inhibiteurs du prot\u00e9asome.&nbsp;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.nature.com\/articles\/s41591-023-02703-y\" target=\"_blank\" rel=\"noopener\" title=\"\">Lire la suite&#8230;<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>En raison de l\u2019\u00e9volution des normes de traitement d\u2019un my\u00e9lome multiple nouvellement diagnostiqu\u00e9, de nombreux patients seront expos\u00e9s aux trois classes de m\u00e9dicaments apr\u00e8s les premi\u00e8res rechutes et pr\u00e9senteront un faible taux de survie. De nouveaux traitements et de nouvelles combinaisons sont donc n\u00e9cessaires pour am\u00e9liorer les r\u00e9sultats des patients. Les m\u00e9dicaments biologiques ciblant l\u2019antig\u00e8ne [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[88,53],"tags":[],"class_list":["post-27206","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-evenement"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/27206","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=27206"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/27206\/revisions"}],"predecessor-version":[{"id":27207,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/27206\/revisions\/27207"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=27206"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=27206"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=27206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}